Abbott Healthcare is facing regulatory scrutiny in India following an investigation into alleged cough syrup abuse, according to official documents. Authorities are examining the company’s practices and compliance standards amid concerns over misuse of pharmaceutical products. The probe highlights growing regulatory vigilance in India’s healthcare sector and its focus on patient safety.
Show moreStay Ahead – Explore Now! Birla Cable CEO R. Sridharan Steps Down Amid Leadership Transition
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
